OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
121
Results
Show all
Save search
Copy query
Show results for
Unknown
(110)
Genomics
(5)
Transcriptomics
(4)
Metabolomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(3)
Mus musculus
(1)
Rattus norvegicus
(1)
Alphavirus
(1)
Archaea
(1)
Bacteria
(1)
Betaherpesvirinae
(1)
Borrelia
(1)
Botrytis cinerea
(1)
Clostridium perfringens
(1)
Eukaryota
(1)
Fungi
(1)
Hepatitis B virus
(1)
Human betaherpesvirus 5
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Insecta
(1)
Japanese encephalitis virus group
(1)
Mammarenavirus
(1)
Miscanthus x giganteus
(1)
Mycobacterium tuberculosis
(1)
Orthoflavivirus
(1)
Panicum virgatum
(1)
Pseudomonas aeruginosa
(1)
Rattus
(1)
Saccharomyces cerevisiae
(1)
Schizosaccharomyces
(1)
Schizosaccharomyces pombe
(1)
Severe acute respiratory syndrome coronavirus 2
(1)
Staphylococcus aureus
(1)
Organisms
Homo sapiens
(3)
Repository
ENA
(5)
geo
(4)
MetaboLights
(1)
pride
(1)
Tissue
Cardiac muscle cell
(1)
Heart
(1)
Technology Type
Mass spectrometry
(1)
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
CHEBI ID
CHEBI:177867
(1)
CHEBI:177866
(1)
CHEBI:73811
(1)
CHEBI:34693
(1)
CHEBI:177865
(1)
CHEBI:9428
(1)
CHEBI:135752
(1)
CHEBI:177864
(1)
CHEBI:81097
(1)
CHEBI:177863
(1)
CHEBI:10027
(1)
CHEBI:6696
(1)
CHEBI:177862
(1)
CHEBI:67975
(1)
CHEBI:177861
(1)
CHEBI:135684
(1)
CHEBI:177860
(1)
CHEBI:65457
(1)
CHEBI:5643
(1)
CHEBI:80857
(1)
CHEBI:177859
(1)
CHEBI:177858
(1)
CHEBI:177857
(1)
CHEBI:94288
(1)
CHEBI:177855
(1)
CHEBI:177854
(1)
CHEBI:65349
(1)
CHEBI:80799
(1)
CHEBI:95040
(1)
CHEBI:5369
(1)
Metabolite Name
Fludorex
(1)
Arg-Arg
(1)
Dicyclohexyl phthalate
(1)
(E)-isoeugenyl benzyl ether
(1)
Tectoridin
(1)
Dexamethasone beloxil
(1)
Rehmaionoside A
(1)
(9Z)-9-Cycloheptadecen-1-ol
(1)
WIN I(S)
(1)
(3S,6S)-3-(4-Hydroxybenzyl)-6-(hydroxymethyl)-2,5-piperazinedione
(1)
Gamma-Glu-gln
(1)
(10Z)-heptadecenoic acid
(1)
Iosefamic acid
(1)
Glycerophosphatidylethanolamine
(1)
Nandrolone cyclotate
(1)
(2E,4Z)-N-Isobutyl-2,4-decadienamide
(1)
Phe-asn
(1)
Terpendole K
(1)
4,4'-(diphenylethenylidene)bis[n,n-dimethylbenzenamine]
(1)
L-Acetyltryptophan
(1)
Andilesin A
(1)
Gosogliptin
(1)
2-Hydroxypropyl stearate
(1)
L-buthionine-(S,R)-sulfoximine
(1)
Pentoxyl
(1)
2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion
(1)
5-{4-[2-(Methylamino)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
(1)
Benzyl 2-({[4-(carbamimidamidomethyl)cyclohexyl]carbonyl}oxy)benzoate
(1)
Mirabegron
(1)
(2R)-2-Hydroxy-3-(phosphonooxy)propyl (13Z,16Z)-13,16-docosadienoate
(1)
First Public Date
2024
(4)
2023
(1)
Release Date
2024
(18)
2023
(16)
2022
(15)
2021
(14)
2025
(8)
2020
(8)
2016
(7)
2019
(5)
2018
(4)
2017
(4)
2014
(4)
2015
(3)
2026
(2)
2012
(1)
2011
(1)
Lab affiliation
Paris Cardiovascular Research Center (PARCC); INSERM UMR970; Université Paris Descartes; Paris, France
(1)
Publication date
2024
(3)
2023
(1)
2021
(1)
2017
(1)
Tags
xref:PubMed:38602915
(1)
xref:PubMed:39811555
(1)
xref:PubMed:36604418
(1)
xref:PubMed:41350901
(1)
xref:PubMed:38884602
(1)
Previous
page
1 / 13
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
13
Next
page
Sort
by:
Relevance
Page size
10
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Not available
S-EPMC6314514
|
biostudies-literature
Cite
Serial mRNA profiling of peripheral blood monocytes from PAH patients treated with phosphodiesterase 5 inhibitors (PDE5i) and PDE5i+macitentan
Serial mRNA profiling of peripheral blood monocytes from PAH patients treated with phosphodiesterase 5 inhibitors (PDE5i) and PDE5i+macitentan
PRJNA999735
|
ENA
Cite
SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation.
Not available
S-EPMC11615754
|
biostudies-literature
Cite
Efficacy and safety of macitentan for pulmonary hypertension: A meta-analysis.
Not available
S-EPMC10632077
|
biostudies-literature
Cite
Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial.
Not available
S-EPMC5772137
|
biostudies-literature
Cite
Distinct ETA receptor binding mode of macitentan as determined by site directed mutagenesis.
Not available
S-EPMC4166607
|
biostudies-literature
Cite
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis.
Not available
S-EPMC12818237
|
biostudies-literature
Cite
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag: a case report.
Not available
S-EPMC9578229
|
biostudies-literature
Cite
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.
Not available
S-EPMC4876803
|
biostudies-literature
Cite
Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study.
Not available
S-EPMC9402487
|
biostudies-literature
Cite
Previous
page
1 / 13
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
13
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
